The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Youlia M. Kirova

Department of Radiation Oncology

Institut Curie

26, rue d'Ulm

75248

France

[email]@curie.net

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Radiation Oncology, Institut Curie, 26, rue d'Ulm, 75248, France. 2005 - 2012

References

  1. Further developments for improving response and tolerance to irradiation for advanced renal cancer: concurrent (mTOR) inhibitor RAD001 and helical tomotherapy. Kirova, Y.M., Servois, V., Chargari, C., Amessis, M., Zerbib, M., Beuzeboc, P. Invest. New. Drugs (2012) [Pubmed]
  2. Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature. Kirova, Y.M., Savignoni, A., Sigal-Zafrani, B., de La Rochefordiere, A., Salmon, R.J., This, P., Asselain, B., Stoppa-Lyonnet, D., Fourquet, A. Breast Cancer Res. Treat. (2010) [Pubmed]
  3. Improving the definition of tumor bed boost with the use of surgical clips and image registration in breast cancer patients. Kirova, Y.M., Castro Pena, P., Hijal, T., Fournier-Bidoz, N., Laki, F., Sigal-Zafrani, B., Dendale, R., Bollet, M.A., Campana, F., Fourquet, A. Int. J. Radiat. Oncol. Biol. Phys. (2010) [Pubmed]
  4. Concurrent involved field radiation therapy and temsirolimus in refractory mantle cell lymphoma (MCL). Kirova, Y.M., Chargari, C., Amessis, M., Vernant, J.P., Dhedin, N. Am. J. Hematol. (2010) [Pubmed]
  5. Can we consider always an esophageal carcinoma as radiation associated cancer after irradiation for breast cancer? Kirova, Y.M., Asselain, B., Fourquet, A. Am. J. Clin. Oncol. (2009) [Pubmed]
  6. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy. Kirova, Y.M., Campana, F., Savignoni, A., Laki, F., Muresan, M., Dendale, R., Bollet, M.A., Salmon, R.J., Fourquet, A. Int. J. Radiat. Oncol. Biol. Phys. (2009) [Pubmed]
  7. How to boost the breast tumor bed? A multidisciplinary approach in eight steps. Kirova, Y.M., Fournier-Bidoz, N., Servois, V., Laki, F., Pollet, G.A., Salmon, R., Thomas, A., Dendale, R., Bollet, M.A., Campana, F., Fourquet, A. Int. J. Radiat. Oncol. Biol. Phys. (2008) [Pubmed]
  8. Second malignancies after breast cancer: the impact of different treatment modalities. Kirova, Y.M., De Rycke, Y., Gambotti, L., Pierga, J.Y., Asselain, B., Fourquet, A. Br. J. Cancer (2008) [Pubmed]
  9. Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review. Kirova, Y.M., Gambotti, L., De Rycke, Y., Vilcoq, J.R., Asselain, B., Fourquet, A. Int. J. Radiat. Oncol. Biol. Phys. (2007) [Pubmed]
  10. Postmastectomy electron beam chest wall irradiation in women with breast cancer: a clinical step toward conformal electron therapy. Kirova, Y.M., Campana, F., Fournier-Bidoz, N., Stilhart, A., Dendale, R., Bollet, M.A., Fourquet, A. Int. J. Radiat. Oncol. Biol. Phys. (2007) [Pubmed]
  11. CT-scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning. Kirova, Y.M., Servois, V., Campana, F., Dendale, R., Bollet, M.A., Laki, F., Fournier-Bidoz, N., Fourquet, A. Radiother. Oncol (2006) [Pubmed]
  12. Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review. Kirova, Y.M., Vilcoq, J.R., Asselain, B., Sastre-Garau, X., Fourquet, A. Cancer (2005) [Pubmed]
  13. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Kirova, Y.M., Stoppa-Lyonnet, D., Savignoni, A., Sigal-Zafrani, B., Fabre, N., Fourquet, A. Eur. J. Cancer (2005) [Pubmed]
 
WikiGenes - Universities